The observed increase in circulating TPO in our study might be explained by decreased consumption of TPO secondary to thrombocytopenia and contradictory data throughout the literature may be related with ignorance of the TPO receptors at bone marrow. The gene discussed is TPO; the disease is Thrombocytopenia.